K. M. Cock

发表

Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections

R. Hayes, S. Kapiga, P. Ghys, 2004, The Lancet.

Estimating HIV incidence using a cross-sectional survey : comparison of three approaches in a hyperendemic setting , Ndhiwa sub-county , Kenya , 2012 Short title : Multiple methods for HIV incidence estimation in Kenya

R. Écochard, J. Etard, B. Riche, 2016 .

A serostatus-based approach to HIV/AIDS prevention and care in Africa

E. Marum, K. M. Cock, D. Mbori-ngacha, 2003, The Lancet.

ART coverage and viral load suppression rates as correlates to HIV positivity in Kenya; Spatial-temporal analyses 2015-17

Anthony K. Waruru, Emily Zielinski-Gutierrez, T. Tylleskär, 2020 .

Elimination of cholera transmission in Haiti and the Dominican Republic

T. Frieden, J. Tappero, J. Andrus, 2012, The Lancet.

Plus ça change ... antiretroviral therapy, HIV prevention, and the HIV treatment cascade.

K. M. Cock, 2014 .

EPIDEMIC YELLOW FEVER IN EASTERN NIGERIA, 1986

B. Okafor, A. Nasidi, R. B. Craven, 1988, The Lancet.

The CDC's Center for Global Health

T. Frieden, K. M. Cock, 2012, The Lancet.

Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'Ivoire

C. Ou, K. Brattegaard, J. R. George, 1992, The Lancet.

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial

J. Karon, A. Grant, S. Wiktor, 1999, The Lancet.

Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire

K. D. de Cock, A. Greenberg, I. Coulibaly, 1995, The Lancet.

The global epidemiology of HIV/AIDS

H. Weiss, K M Cock, H A Weiss, 2000, Tropical medicine & international health : TM & IH.

Use of viral load to improve survey estimates of known HIV-positive status and antiretroviral treatment coverage in Kenya

Anthony K. Waruru, M. Kretzschmar, A. Kim, 2019 .

A call for coordinated and evidence-based action to protect children outside of family care

A. Pablos-Mendez, E. Goosby, S. Polaski, 2012, The Lancet.

A public health approach to global management of hypertension

T. Frieden, S. Angell, K. M. Cock, 2015, The Lancet.

Tuberculosis: Pathogenesis, protection, and control - B. R. Bloom (editor). Washington, DC: American Society for Microbiology, 1994. xv + 637pp. Price @$57.50. ISBN 1-55581-072-1

Kevin M. De Cock, K. M. Cock, 1995 .

HIV testing in the era of treatment scale up.

K. M. Cock, 2005 .

HIV in the United States at the turn of the century: an epidemic in transition.

R. Steketee, J. Karon, K. D. de Cock, 2001, American journal of public health.

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

M. Fowler, É. Mercier, K. D. de Cock, 2000, JAMA.

Sexually transmitted diseases and human immunodeficiency virus infections in women attending an antenatal clinic in Abidjan, Cote d'Ivoire

V. Ettiègne-Traoré, K. D. de Cock, M. Laga, 1997, International journal of STD & AIDS.

The public health implications of AIDS research in Africa.

H. Gayle, K. D. de Cock, E. Ekpini, 1994, JAMA.

Tuberculosis and HIV infection in sub-Saharan Africa.

K. D. de Cock, I. Coulibaly, S. Lucas, 1992, JAMA.

Pneumocystis carinii infection: current treatment and prevention.

R. Miller, K. D. de Cock, E. Corbett, 1996, The Journal of antimicrobial chemotherapy.

HIV/AIDS among African Americans: progress or progression?

H. Gayle, M. Gwinn, R. Selik, 2000, AIDS.

Declines in AIDS incidence and deaths in the USA: a signal change in the epidemic.

J. Ward, J. Karon, K. D. de Cock, 1998, AIDS.

Nocardiosis in HIV-positive patients: an autopsy study in West Africa.

C. Peacock, K. D. de Cock, S. Lucas, 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Game changers: why did the scale-up of HIV treatment work despite weak health systems?

W. El-Sadr, K. D. de Cock, T. A. Ghebreyesus, 2011 .

Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction.

L. Goldstein, S. Lee, J. Sninsky, 1988, The Journal of infectious diseases.

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

H. Gayle, K. D. de Cock, E. Ekpini, 1993, JAMA.

Contribution of tuberculosis to slim disease in Africa

M. Diomande, C. Peacock, K. D. de Cock, 1994, BMJ.

Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study.

R. Hayes, Brett Williams, T. Clayton, 1999, American journal of respiratory and critical care medicine.

The impact of human immunodeficiency virus infection on pelvic inflammatory disease: A case‐control study in Abidjan, Ivory Coast

H. Gayle, K. Holmes, P. Ghys, 1995, American journal of obstetrics and gynecology.

Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast.

H. Gayle, K. D. de Cock, C. Ou, 1994, JAMA.

Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast.

P. Piot, P. Ghys, V. Ettiègne-Traoré, 1995, The Journal of infectious diseases.

Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast.

M. Lafontaine, K. D. de Cock, Gene E. Bretton, 1991, BMJ.

Delta hepatitis in the Los Angeles area: a report of 126 cases.

K. D. de Cock, S. Govindarajan, A. Redeker, 1986, Annals of internal medicine.